Skip to content
PeptideAgent

Telehealth providers in New Jersey

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

Telehealth prescribing is allowed in New Jersey, but not asynchronous care. What New Jersey requires of telehealth prescribers and pharmacies, plus verified listings.

New Jersey at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async not allowed
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified telehealth providers serving New Jersey

No verified telehealth providers serving New Jersey are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Telehealth prescribing rules in New Jersey

N.J.S.A. 45:1-61 through 45:1-66 (P.L.2017, c.117) let a New Jersey-licensed health care provider establish a provider-patient relationship and treat through telemedicine, held to the in-person standard of care. Section 2(c) of P.L.2017, c.117 (N.J.S.A. 45:1-62) says telemedicine services shall be provided using interactive, real-time, two-way communication technologies. Asynchronous store-and-forward technology may be used to transmit images, diagnostics, data, and medical information, and real-time two-way audio without video may be combined with store-and-forward only if, after reviewing the patient's medical records, the provider determines the in-person standard of care can be met. For an initial encounter the provider must review the patient's medical history and records before contact. The Board of Medical Examiners' rule N.J.A.C. 13:35-6B.5 adds that physician telemedicine must include a video component unless that audio exception applies. Because both the statute and the rule require a real-time interaction, this record treats questionnaire-only asynchronous prescribing as not allowed. Schedule II prescribing by telemedicine requires an initial in-person exam and in-person visits every three months, but that rule does not apply to the non-controlled peptides in this database. [2] [3] [4] [8]

Compounded GLP-1 access in New Jersey

Compounded semaglutide and tirzepatide are limited to the federal exception for documented patient specific needs because the FDA shortage allowances ended in 2025, and the Board's 2023 statement independently bars semaglutide salt forms and requires documented, FDA-registered sourcing of semaglutide base. [9] [12]

Research use only sellers in New Jersey

New Jersey's food and drug law (N.J.S.A. Title 24) prohibits selling adulterated or misbranded drugs, and the Pharmacy Practice Act limits dispensing to licensed pharmacies. The Board's semaglutide statement also warns pharmacies against non-pharmaceutical-grade ingredients. [9] [10] [13]

How to check a telehealth provider in New Jersey

  1. Confirm the prescriber is licensed or registered to treat patients located in New Jersey; the telehealth rules above explain what New Jersey requires. [2] [3] [4] [8]
  2. Ask which pharmacy will fill the prescription and check it in the New Jersey State Board of Pharmacy (Division of Consumer Affairs) license lookup. [1] [5] [6] [7] [9] [11]
  3. Get the full price in writing first: consult fees, membership fees, and the medication itself.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in New Jersey. [9] [10] [13]

Sources

  1. [1]New Jersey State Board of Pharmacy (Division of Consumer Affairs)
  2. [2]N.J.S.A. 45:1-61, Definitions relative to telemedicine and telehealth
  3. [3]N.J.S.A. 45:1-62, Provision of health care through telemedicine or telehealth; requirements
  4. [4]New Jersey P.L.2017, c.117 (S291), Telemedicine and Telehealth Act
  5. [5]New Jersey Pharmacy Practice Act, N.J.S.A. 45:14-40 and following, and N.J.A.C. 13:39 (Board laws and regulations)
  6. [6]N.J.S.A. 45:14-73, Registration of out-of-State pharmacies; requirements
  7. [7]N.J.A.C. 13:39-4.20, Out-of-State pharmacy registration
  8. [8]N.J.A.C. 13:35-6B.5, Provision of health care services through telemedicine or telehealth (Board of Medical Examiners)
  9. [9]New Jersey State Board of Pharmacy: Statement concerning semaglutide compounding (posted version dated November 6, 2023)
  10. [10]N.J.S.A. Title 24, Food and drugs